Assessment of hepatocellular damage and hematological alterations in mice chronically fed p-dimethyl aminoazobenzene and phenobarbital

Experimental and Molecular Pathology

Volumn 83, Issue 1, 2007, Pages 104-111

  Pathak, Surajit ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Carcinogenesis; Hemoglobin; Hormone; Matrix metalloproteinase; p dimethyl aminoazobenzene; Phenobarbital; Reduced glutathione; Restriction endonuclease; Scanning electron microscopy; Transmission electron microscopy

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; CHOLESTEROL; ESTRADIOL; GLUCOSE; GLUTATHIONE; HEMOGLOBIN; HYDROCORTISONE; MATRIX METALLOPROTEINASE; PHENOBARBITAL; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOLOGY; ESTRADIOL BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HYDROCORTISONE BLOOD LEVEL; LIVER CELL DAMAGE; LYMPHOCYTE; MOUSE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TESTOSTERONE BLOOD LEVEL; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CHOLESTEROL; ESTRADIOL; FEMALE; GLUTATHIONE; HEMATOLOGIC TESTS; HEMOGLOBINS; HYDROCORTISONE; LYMPHOCYTES; MALE; MATRIX METALLOPROTEINASES; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; P-DIMETHYLAMINOAZOBENZENE; SPLEEN; TESTOSTERONE; TIME FACTORS;

MUS; MUS MUSCULUS;

EID: 34249735959     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.10.003     Document Type: Article

References (67)

1. Akamatsu Y., and Ikegami R. Induction of hepatoma and systemic amyloidosis in mice by 4-(dimethylamino) azobenezene feeding. Gann 59 (1968) 201-206
2. Billings P.C., Habres J.M., Liao D.C., and Tuttle S.W. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res. 51 (1991) 5539-5543
3. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7 (1995) 728-735
4. Biswas S.J., and Khuda-Bukhsh A.R. Evaluation of protective potentials of a homeopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice. Indian. J. Exp. Biol. 42 (2004) 698-714
5. Biswas S.J., and Khuda-Bukhsh A.R. Cytotoxic and genotoxic effects of the azo-dye p-dimethylaminoazobenzene in mice: a time-course study. Mutat. Res. 587 (2005) 1-8
6. Biswas S.J., Pathak S., and Khuda-Bukhsh A.R. Assessment of the genotoxic and cytotoxic potential of an anti-epileptic drug, phenobarbital, in mice: a time course study. Mutat. Res. 563 (2004) 1-11
7. Cauley J.A., Lucas F.L., Kuller L.H., Stone K., Browner W., and Cummings S.R. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer: study of Osteoporotic Fractures Research Group. Ann. Intern. Med. 130 (1999) 270-277
8. Christensen J., Gonzales A., Cattley R., and Goldsworthy T. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ. 9 (1998) 815-825
9. Corkoran G., Fix L., Jones D., Moslen M., Nicotera P., Oberhammer F., and Buttyan R. Contemporary issues in toxicology. Apoptosis: molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128 (1994) 169-181
10. Daoust R., and Molnar F. Cellular populations and mitotic activity in rat liver parenchyma during azo dye carcinogenesis. Cancer Res. 24 (1964) 1898-1909
11. David G.F.X., Herbert J., and Wright C.D.S. The ultra structure of the pineal ganglion in the ferret. J. Anat. 115 (1973) 79
12. Dikranian K., Olney J.W., and Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl. Acad. Sci. U. S. A. 99 23 (2002) 15089-15092
13. Eagon P.K., Chandar N., Epley M.J., Elm M.S., Brady E.P., and Rao K.N. Di (2-ethylhexyl) phthalate-induced changes in liver estrogen metabolism and hyperplasia. Int. J. Cancer 58 5 (1994) 736-743
14. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959) 70-77
15. Fisher R.A., and Yates F. Statistical Tables for Biological, Agricultural and Medical Research. 6th edition (1963), Oliver and Boyd, Edinburgh
16. Gold E.B., Gordis L., Tonascia J.A., and Szklo M. Brain tumors in children exposed to barbiturates. J. Natl. Cancer Inst. 63 (1979) 3-4
17. Haseman J., and Lockhart A. The relationship between uses of the wax tolerated dose and study sensitivity for detecting rodent carcinogenecity. Fundam. Appl. Toxicol. 22 (1994) 382-391
18. Hirtle J., Meyer S., and Brockenbrough J. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. In: Butterwortyh B., Slaga T., Farland W., and McClain M. (Eds). Chemically Induced Cell Proliferation: Implications for Risk Assessment (1991), Wiley-Liss, New York 209-216
19. Hong S.K., Anestis D.K., Valentovic M.A., Ball J.G., Brown P.I., and Rankin G.O. Gender differences in the potentiation of N-(3,5-dichlorophenyl) succinimide metabolite neprotoxicity by phenobarbital. J. Toxicol. Environ. Health 64 3 (2001) 241-256
20. International Agency for Research on Cancer (IARC). Some aromatic azo compounds. IARC Monogr. Eval. Carcinog. Risks Chem. Hum. 8 (1975) 357
21. International Agency for Research on Cancer (IARC). Chemicals, industrial processes and industries associated with cancer in humans. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans vol. 4 (1982), IARC, Lyon, France 292
22. International Agency for Research on Cancer (IARC). On the evaluation of carcinogenic risk of chemicals to man. Group 2B 7 (1987) 440
23. International Agency for Research on Cancer (IARC). Summaries and evaluations, phenobarbital and its sodium salt. Group 2B 79 (2001) 161-162
24. Jayaprasad N., Anees T., Bijin T., and Madhusoodanan S. Severe hypoglycemia due to poorly differentiated hepatocellular carcinoma. J. Assoc. Physicians India 54 (2006) 413-415
25. Karasaki S. Cell proliferation and subcellular localization of alkaline phosphatase activity in rat liver parenchyma during azo dye carcinogenesis. Cancer Res. 35 (1975) 482-491
26. Kinoshita A., Wanibuchi H., Wei K.M., Shen J., Imaoka S., Funae Y., and Fukushima S. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis 24 8 (2003) 1389-1399
27. Kitagawa T., and Sugano H. Enhancement of azo-dye hepatocarcinogenesis with dietary phenobarbital in rats. Gann 68 (1977) 255-256
28. Kitagawa T., and Sugano H. Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3'-methyl-4-(dimethylamino) azobenzene or diethylnitrosamine. Gann 69 5 (1978) 679-687
29. Kitagawa T., Pitot H.C., Miller E.C., and Miller J.A. Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat. Cancer Res. 39 1 (1979) 112-115
30. Kitagawa T., Hino O., Nomura K., and Sugano H. Dose-response studies on promoting and anti-carcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Carcinogenesis 5 (1984) 1653-1656
31. Kolaja K., Stevensen D., Walborg E., and Klaunig J. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis 17 (1996) 947-954
32. Kuper H., Mantzoros C., Lagiou P., Tzonou A., Tamimi A., Mucci L., Benetou L., Spanos E., Stuver S., and Trichopoulos D. Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men. Oncology 60 (2001) 355-360
33. Kwok A.K.H., Yeung C.K., Lai T.Y.Y., Chan K.P., and Pang C.P. Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells. Br. J. Ophthalmol. 88 (2004) 1590-1594
34. Lee G.H. Paradoxical effects of phenobarbital on mouse carcinogenesis. Toxicol. Pathol. 28 (2000) 215-225
35. Lee A.Y., Akers K.T., Collier M., Li L., Eisen A.Z., and Seltzer J.L. Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4424-4429
36. Liotta L.A., Steeg P.S., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
37. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin-Phenol reagent. J. Biol. Chem. 193 (1951) 265-275
38. Maekawa A., Onodera H., Ogasawara H., Matsushima Y., Mitsomuri K., and Hayashi Y. Threshold dose-dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine. Carcinogenesis 13 (1992) 501-503
39. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling (Review). Trends Genet. 6 (1990) 121-125
40. Melnick R., and Huff J. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation. Toxicol. Ind. Health 9 (1993) 415-438
41. Merck. The Merck Index. 10th ed. (1983), Merck & Company, Inc., Rahway, NJ
42. National Institute for Occupational Safety and Health, 2004. http://www.cde.gov/niosh/npotocca.html.
43. Nesn S., Argus M., Bergman H., Chu K., Frith C., Helmes T., Mcgaughy R., Ray V., Slaga T.J., Tennant R., and Weisburger E. Chemical carcinogenesis: a review and analysis of the literature of selected chemicals and the establishment of the gene-tox carcinogen database: a report of the US. Environmental Protection Agency gen-tox program. Mutat. Res. 185 (1987) 1-195
44. Nikeghbalian S., Bananzadeh A., and Yarmohammadi H. Hypoglycemia, the first presenting sign of hepatocellular carcinoma. Saudi Med. J. 27 3 (2006) 378-387
45. NTP. Report on Carcinogens, 2005. Eleventh edition. Research Triangle Park, NC: National Toxicology Program. http://ntp.niehs.nih.gov/index.cfm?Objectid=32BA9724-F1F6-975E-7FCE50709CB4C932.
46. Palekar S.D., and Sirsat S.M. Studies on the hepatocyte in azo dye carcinogenesis. Indian. J. Exp. Biol. (1966) 473-478
47. Pathak S., Das J.K., Biswas S.J., and Khuda-Bukhsh A.R. Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice. Mol. Cell. Biochem. 285 (2006) 121-131
48. Peraino C., Staffeldt E.F., Haugen D.A., Lombard L.S., Stevens F.J., and Fry R.J.M. Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 40 (1980) 3268-3273
49. Pitot H.C., Goldsworthy T.L., Moran S., Kennan W., Glauert H.P., Maronpot R.R., and Campbell H.A. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 8 (1987) 1491-1499
50. Plant N., Horley N., Dickins M., Hasmall S., Elcombe C., and Bell D. The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate. Carcinogenesis 19 (1998) 1521-1527
51. Plummer D.T. An Introduction to Practical Biochemistry. 3rd edn. (1988), Tata. McGraw. Pub. Co. Ltd., New Delhi 197-198
52. Ray J.M., and Stetler-Stevenson W.G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7 (1994) 2062-2072
53. Seltzer J.L., Lee A.Y., Akers K.T., Sudbeck B., Southon E.A., Wayner E.A., and Eisen A.Z. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp. Cell Res. 213 (1994) 365-374
54. Siemiatycki J., Richardson L., Straif K., Latreille B., Lakhani R., Cambell S., Roussean M.C., and Boffetta P. Listing occupational carcinogens: research review. Environ. Health Perspect. 112 (2004) 1447-1459
55. Sternlicht M.D., and Werb Z. How matrix metalloproteases regulate cell behaviour. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
56. Thipaporn T., Bubpha P., and Varaphon V. Hepatocellular carcinoma with persistent hypoglycemia: successful treatment with corticosteroid and frequent high carbohydrate intake. J. Med. Assoc. Thailand 88 12 (2005) 1941-1946
57. Tsuda S., Murakami M., Matsusaka N., Kano K., Taniguchi K., and Sasaki Y.F. DNA damage induced by red food dyes orally administered to pregnant and male mice. Toxicol. Sci. 61 (2001) 92-99
58. Tsutsui S., Yamamoto R., Iishi H., Tatsuta M., Tsuji M., and Terada N. Promoting effect of ovariectomy on hepatocellular tumorigenesis induced in mice by 3′-methyl-4-dimethylaminoazobenzene. Virchows Arch., B. Cell Pathol. Incl. Mol. Pathol. 62 6 (1992) 371-375
59. Uchida E., and Hirono I. Effect of phenobarbital on induction of liver and lung tumors by dimethylnitrosamine in newborn mice. Gann 70 (1979) 639-644
60. Uchida E., and Hirono I. Effect of phenobarbital on the development of neoplastic lesions in the liver of cycasin-treated rats. J. Cancer Res. Clin. Oncol. 100 (1981) 231-238
61. Wang Z., Juttermann R., and Soloway P.D. TIMP-2 is required for efficient activation of pro MMP-2 in vivo. J. Biol. Chem. 275 (2000) 26411-26415
62. White S.J., McLean A.E.M., and Howland C. Anticonvulsant drugs and cancer, a cohort study in patients with severe epilepsy. Lancet ii (1979) 458-461
63. Woessner Jr. J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5 (1991) 2145-2154
64. Yamamoto R., Iishi H., Tatsuta M., Tsuji M., and Terada N. Roles of ovaries and testes in hepatocellular tumorigenesis induced in mice by 3′-methyl-4-dimethylaminoazobenzene. Int. J. Cancer 49 1 (1991) 83-88
65. Yamamoto R., Iishi H., Tatsuta M., Tsuji M., and Terada N. Suppressive effect of estrogen on hepatocellular tumorigenesis induced in mice by 3′-methyl-4-dimethylaminoazobenzene. Exp. Toxicol. Pathol. 45 5-6 (1993) 325-328
66. Yeung R.T. Hypoglycaemia in hepatocellular carcinoma: a review. Hong Kong Med. J. 3 3 (1997) 297-301
67. Zhang K., and Chow P.K.H. The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo. Clin. Cancer Res. 10 (2004) 5226-5232